
Lewis Moody, the former England rugby captain and 2003 World Cup winner, was diagnosed with motor neurone disease (MND) in 2025 after a persistent weakness in his left shoulder led to scans revealing nerve damage. Now 47, he is confronting the disease with characteristic resolve and turning his remaining energy into advocacy.
Former England rugby player: Lewis Moody ·
Age: 47 (born 12 June 1978) ·
Diagnosis: Motor Neurone Disease (MND) in 2025 ·
Leicester Tigers appearances: 217 ·
World Cup winner: 2003
Quick snapshot
- Leicester Tigers legend — 217 appearances (BBC Sport)
- England international — 71 caps, captain (The Telegraph)
- World Cup winner — 2003 (BBC Sport)
- Married with three children
- Lives near Bath
- Active in charity work
- Founded Lewis Moody Foundation (Sky Sports)
- Raises funds for research (Sky Sports)
- Speaks publicly about living with MND (The Guardian)
Seven key facts that define Moody’s career and diagnosis at a glance.
| Label | Value |
|---|---|
| Full name | Lewis Walton Moody |
| Date of birth | 12 June 1978 |
| Sport | Rugby union |
| Position | Flanker |
| England caps | 71 (The Telegraph) |
| Leicester Tigers appearances | 217 (BBC Sport) |
| World Cup | 2003 winner (BBC Sport) |
| Diagnosed condition | Motor Neurone Disease (MND) |
What has happened to Lewis Moody?
When was Lewis Moody diagnosed?
- Lewis Moody received a diagnosis of motor neurone disease in 2025, at age 47 (BBC Sport, UK sports broadcaster).
- He made the news public in October 2025, telling BBC Breakfast viewers that the diagnosis had come roughly two weeks earlier (BBC Sport).
- England Rugby described the development as heartbreaking, with a spokesperson saying the rugby community was behind him (Sporting News UK, sports media outlet).
How did the news become public?
Moody chose a BBC Breakfast interview to announce the diagnosis, appearing composed and candid. “I feel nothing’s wrong,” he said at the time, acknowledging the strange gap between how he felt and what the scans had shown (BBC Sport). The interview prompted an outpouring of support from former teammates, fans, and the wider rugby world.
Moody’s public announcement so soon after his own diagnosis — roughly two weeks — signals a deliberate choice to frame his narrative early rather than let speculation fill the void.
The implication: Moody is taking control of his story, using his platform to steer public attention toward MND research and awareness rather than letting the disease define him in private.
How did Lewis Moody know he has MND?
What symptoms did he first notice?
- Moody first noticed a persistent weakness in his left shoulder while training in the gym (BBC Sport).
- He visited a physiotherapist, but the weakness did not improve — a red flag that pushed him toward further investigation (The Guardian, UK newspaper).
- The Guardian reported that the shoulder symptom was mild — not dramatic — which made the eventual diagnosis all the more jarring for Moody (The Guardian).
How was the diagnosis confirmed?
When physiotherapy failed to resolve the shoulder weakness, Moody underwent scans that revealed nerve damage in his brain and spinal cord (BBC Sport). Specialist consultations followed, and the diagnosis of MND was confirmed. Moody told Sky Sports that the entire process — from first noticing the weakness to receiving the diagnosis — took several months (Sky Sports, sports news outlet).
A mild gym niggle led to a life-altering diagnosis. Moody’s case highlights how MND can begin with barely noticeable symptoms, making early detection a persistent challenge for clinicians.
The pattern: MND often announces itself not with dramatic collapse but with subtle losses — a shoulder that won’t lift, a grip that slackens — that people dismiss as aging or overtraining until medical evidence says otherwise.
What does Lewis Moody do now?
Is he still involved in rugby?
- Moody works as a performance coach at KBM Inspired, a company he co-founded that focuses on mindset and leadership training (Sky Sports).
- He remains connected to the rugby community, attending matches and mentoring younger players.
- His work blends experience from 217 Leicester Tigers appearances and 71 England caps into coaching programmes for athletes and corporate clients.
What advocacy work is he doing?
Moody founded the Lewis Moody Foundation to fund MND research and raise awareness about the disease. In a Sky Sports interview in 2026, he said: “I want to have as big an impact on motor neurone disease as possible in the time I have to move things forward.” The foundation has already begun fundraising campaigns, with Moody using his public profile to attract donations and partnerships (Sky Sports).
“I want to have as big an impact on motor neurone disease as possible in the time I have to move things forward.”
— Lewis Moody, speaking to Sky Sports
Moody’s foundation is still in its early phase. Whether it can replicate the fundraising success of similar athlete-led health initiatives will depend on how rapidly MND research delivers tangible progress.
The trade-off: every hour Moody spends on advocacy is an hour he cannot spend with his family, but he has chosen the longer lever — funding research — over private time, a calculation he has made explicit in interviews.
How long has Lewis Moody got to live?
What is the typical life expectancy with MND?
- Average life expectancy after an MND diagnosis is 2 to 5 years (NHS, UK health authority).
- Median survival from symptom onset is around 3 years (MND Association, UK charity).
- Around 10% of patients live longer than 10 years, particularly those with slower-progressing forms of MND (NHS).
How does his case compare?
Moody has not publicly given a specific prognosis. He has stated that he wants to make the most of his remaining time, and in a Guardian interview in June 2026, eight months after his diagnosis, he described the experience as “a gift and a privilege” — not the language of someone focused on counting months. “The present is all you have,” he told the Guardian (The Guardian).
“It’s a gift and a privilege. The present is all you have.”
— Lewis Moody, speaking to the Guardian
The catch: while MND’s average prognosis is well understood, individual trajectories vary widely. Moody’s age (47) and general fitness may work in his favour, but no reliable predictors exist for how his specific form of the disease will progress. The uncertainty is part of the condition.
What is the life expectancy with MND?
Does life expectancy vary by type of MND?
- MND is a group of neurodegenerative diseases that affect motor neurons. The most common form is amyotrophic lateral sclerosis (ALS), which accounts for about 60-70% of cases (NHS).
- Other forms include progressive bulbar palsy (PBP), which affects speech and swallowing, and primary lateral sclerosis (PLS), which progresses more slowly (MND Association).
- Life expectancy differs by subtype: ALS patients typically survive 2-5 years, while some PLS patients may live 10-20 years after onset (NHS).
What factors influence survival?
- Age at onset — younger patients tend to have slower progression (MND Association).
- Type of MND — bulbar-onset MND typically has a shorter survival than limb-onset (NHS).
- Respiratory function — patients who maintain respiratory muscle strength generally live longer (MND Association).
- Multidisciplinary care — access to specialist clinics, nutritional support, and non-invasive ventilation can extend survival (NHS).
MND remains incurable. The 2-5 year average survival window has not shifted dramatically in decades, and no breakthrough has changed the trajectory for most patients — which is why Moody’s foundation focus on research funding matters so acutely.
Why this matters: the variability in MND progression means that clinical trials for new treatments face difficult design challenges. Without reliable biomarkers, measuring improvement is slow, and small patient populations make statistical significance hard to reach. Moody’s public platform could help accelerate recruitment into trials.
Timeline signal
- 1996–2010 — Plays for Leicester Tigers, winning multiple English and European titles (BBC Sport)
- 2003 — Wins Rugby World Cup with England (BBC Sport)
- 2025 — Diagnosed with MND after scans reveal nerve damage (BBC Sport)
- October 2025 — Publicly announces diagnosis on BBC Breakfast; begins advocacy work (BBC Sport)
Confirmed facts
- Lewis Moody was diagnosed with MND in 2025 at age 47 (BBC Sport)
- His first symptom was left shoulder weakness (BBC Sport)
- He made the diagnosis public in October 2025 (BBC Sport)
- He is a former England rugby player and captain (The Telegraph)
- He won the 2003 Rugby World Cup with England (BBC Sport)
- He has established the Lewis Moody Foundation for MND research (Sky Sports)
What’s unclear
- Exact life expectancy for Moody — he has not shared a prognosis (The Guardian)
- Cause of his MND — no definitive trigger has been identified (Sky Sports)
- Future progression speed — MND trajectories vary widely and are unpredictable (NHS)
- Whether his MND is bulbar-onset or limb-onset — not publicly specified
- Whether he is receiving riluzole or other treatments — not disclosed
- Exact date of diagnosis — only the year 2025 is known
“There is no concrete, definitive link between rugby and MND.”
— Dr Nick Cole, quoted by Sky Sports
The lack of a proven link between rugby and MND is an important nuance given how many former rugby players have been diagnosed. Dr Nick Cole’s statement does not rule out a connection, but it underscores that the science has not established one.
For Moody and his family — his wife and three children — the clarity around the diagnosis is matched only by the uncertainty of what comes next. He has chosen to fill that uncertainty with action, funding research and speaking publicly in hopes that his remaining time shifts the odds for others.
If you would like to learn more about another sports figure facing a life-changing health diagnosis, read our feature Alan Davies: Cancer, Friendships, and Career. For a different look at a sports legend navigating health and career changes, see Tiger Woods 2026: Current Health, Relationship & Golf Comeback.
bbc.com, youtube.com, theguardian.com, bbc.com, skysports.com, walesonline.co.uk, mirror.co.uk
Frequently asked questions
What is motor neurone disease (MND)?
MND is a progressive neurodegenerative disease that affects the motor neurons in the brain and spinal cord. It leads to muscle weakness, loss of mobility, and eventually affects breathing and swallowing. There is currently no cure (NHS).
How is MND diagnosed?
Diagnosis involves a combination of neurological examination, electromyography (EMG), nerve conduction studies, and MRI scans to rule out other conditions. It often takes months to confirm (NHS).
Is MND the same as ALS?
ALS (amyotrophic lateral sclerosis) is the most common form of MND, accounting for about 60-70% of cases. The terms are often used interchangeably, but MND is a broader category that includes several subtypes (MND Association).
What treatments are available for MND?
Treatments focus on managing symptoms and maintaining quality of life. Riluzole is the only medication licensed in the UK that modestly slows progression. Supportive care includes physiotherapy, speech therapy, nutritional support, and non-invasive ventilation (NHS).
Can MND be cured?
No. MND is incurable, and current treatments only modestly slow progression. Research is ongoing, with clinical trials exploring gene therapies, neuroprotective agents, and stem cell approaches (MND Association).
How common is MND in rugby players?
A number of former rugby players have been diagnosed with MND, including Rob Burrow, Doddie Weir, and now Lewis Moody. However, Dr Nick Cole has stated there is no proven statistical link between playing rugby and developing MND (Sky Sports).
What is the Lewis Moody Foundation?
The Lewis Moody Foundation is a charitable organisation founded by Moody after his diagnosis. It raises funds for MND research and aims to increase public awareness of the disease (Sky Sports).
How can I support MND research?
Donations can be made to organisations such as the MND Association, the Lewis Moody Foundation, or other research charities. Participating in clinical trials and raising awareness also helps accelerate progress (MND Association).